# EDGAR Filing Document

**Accession Number:** 0001167028
**File Stem:** 0001415889-23-001242
**Filing Date:** 2023-1
**Character Count:** 14608
**Document Hash:** 206813c4382eed547ad516756292d044
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001415889-23-001242.hdr.sgml**: 20230119

**ACCESSION NUMBER**: 0001415889-23-001242

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20230117

**FILED AS OF DATE**: 20230119

**DATE AS OF CHANGE**: 20230119

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** SMITH PATRICK W
- **CENTRAL INDEX KEY:** 0001167028

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-16391
- **FILM NUMBER:** 23538699

**MAIL ADDRESS:**
- **STREET 1:** 7860 EAST MCCLAIN DRIVE
- **STREET 2:** SUITE 2
- **CITY:** SCOTTSDALE
- **STATE:** AZ
- **ZIP:** 85260-1627
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AXON ENTERPRISE, INC.
- **CENTRAL INDEX KEY:** 0001069183
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORDNANCE & ACCESSORIES, (NO VEHICLES/GUIDED MISSILES) [3480]
- **IRS NUMBER:** 860741227
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 17800 N. 85TH ST.
- **CITY:** SCOTTSDALE
- **STATE:** AZ
- **ZIP:** 85255
- **BUSINESS PHONE:** 480-991-0797

**MAIL ADDRESS:**
- **STREET 1:** 17800 N. 85TH ST.
- **CITY:** SCOTTSDALE
- **STATE:** AZ
- **ZIP:** 85255

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TASER INTERNATIONAL INC
- **DATE OF NAME CHANGE:** 20010212

## Ex-24

**POWER OF ATTORNEY**

Know all by these presents that the undersigned hereby constitutes and appoints each of Joshua Isner, Brittany Bagley and Isaiah Fields, or either of them signing singly, and with full power of substitution, the undersigned's true and lawful attorney-in-fact to:

(1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer or director of Axon Enterprise, Inc. (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendments thereto, and timely file such form with the U.S. Securities and Exchange Commission (the "SEC") and any stock exchange or similar authority, including without limitation the filing of a Form ID or any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC;

(3) seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to each of the undersigned's attorneys-in-fact appointed by this Power of Attorney and approves and ratifies any such release of information; and

(4) take any other action in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever required, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request and on behalf of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with, or any liability for the failure to comply with, Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, or 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.![](graphic-01182023_110119.jpg)

IN WITNESS WHEREOF the undersigned has caused this Power of Attorney to be executed as of this 19th day of December 2022.

/s/ Patrick Smith

Signature

Patrick Smith

Print Name

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>SMITH PATRICK W<br><sub>(Last) (First) (Middle)</sub><br>17800 NORTH 85TH STREET<br><sub>(Street)</sub><br>SCOTTSDALE, AZ 85255<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-01-17 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_CHIEF EXECUTIVE OFFICER_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>AXON ENTERPRISE, INC. [ AXON ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-01-17 |  | M |  | 117753 | A | $184.47 | 2326233 | D |  |
| Common Stock | 2023-01-17 |  | S<sup>(1)</sup> |  | 54057 | D | 185.3509<sup>(2)</sup> | 2272176 | D |  |
| Common Stock | 2023-01-17 |  | S<sup>(1)</sup> |  | 3142 | D | 186.4723<sup>(3)</sup> | 2269034 | D |  |
| Common Stock | 2023-01-17 |  | S<sup>(4)</sup> |  | 5638 | D | 186.4723<sup>(3)</sup> | 2263396 | D |  |
| Common Stock | 2023-01-17 |  | S<sup>(4)</sup> |  | 6262 | D | 187.4717<sup>(5)</sup> | 2257134 | D |  |
| Common Stock | 2023-01-17 |  | S<sup>(4)</sup> |  | 2400 | D | 188.3060<sup>(6)</sup> | 2254734 | D |  |
| Common Stock | 2023-01-18 |  | M |  | 60229 | A | $182.27 | 2314963 | D |  |
| Common Stock | 2023-01-18 |  | S<sup>(1)</sup> |  | 9336 | D | 185.4596<sup>(2)</sup> | 2305627 | D |  |
| Common Stock | 2023-01-18 |  | S<sup>(1)</sup> |  | 6336 | D | 186.6029<sup>(7)</sup> | 2299291 | D |  |
| Common Stock | 2023-01-18 |  | S<sup>(1)</sup> |  | 13314 | D | 187.4424<sup>(8)</sup> | 2285977 | D |  |
| Common Stock | 2023-01-18 |  | S<sup>(4)</sup> |  | 4447 | D | 187.4424<sup>(8)</sup> | 2281530 | D |  |
| Common Stock | 2023-01-18 |  | S<sup>(4)</sup> |  | 2800 | D | 188.2809<sup>(9)</sup> | 2278730 | D |  |
| Common Stock | 2023-01-19 |  | M |  | 2140 | A | $184.06 | 2280870 | D |  |
| Common Stock | 2023-01-19 |  | S<sup>(1)</sup> |  | 1040 | D | 185.0598<sup>(10)</sup> | 2279830 | D |  |
| Common Stock | 2023-01-19 |  | S<sup>(4)</sup> |  | 260 | D | 185.0598<sup>(10)</sup> | 2279570 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Employee Stock Option | $28.58 | 2023-01-17 |  | M |  |  | 117753 | 2021-06-30 | 2028-02-28 | Common Stock | 117753 | $0 | 1259228 | D |  |
| Employee Stock Option | $28.58 | 2023-01-18 |  | M |  |  | 60229 | 2021-06-30 | 2028-02-28 | Common Stock | 60229 | $0 | 1198999 | D |  |
| Employee Stock Option | $28.58 | 2023-01-19 |  | M |  |  | 2140 | 2021-06-30 | 2028-02-28 | Common Stock | 2140 | $0 | 1196859 | D |  |

---

### Footnotes:

(1) Securities disposed represent securities sold to settle the reporting person's tax liability and exercise price pursuant to a filed Rule 10b5-1 plan. The remainder of the shares, with the exception of those reported on this Form 4, are subject to a 2.5 year holding period.

(2) The transaction was executed in multiple trades at prices ranging from $185.00 to $185.98. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

(3) The transaction was executed in multiple trades at prices ranging from $186.00 to $186.96. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

(4) This sale of vested restricted stock units was executed pursuant to a filed Rule 10b5-1 plan.

(5) The transaction was executed in multiple trades at prices ranging from $187.00 to $187.99. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

(6) The transaction was executed in multiple trades at prices ranging from $188.15 to $189.00. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

(7) The transaction was executed in multiple trades at prices ranging from $186.00 to $186.93. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

(8) The transaction was executed in multiple trades at prices ranging from $187.01 to $187.94. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

(9) The transaction was executed in multiple trades at prices ranging from $188.05 to $188.56. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

(10) The transaction was executed in multiple trades at prices ranging from $185.00 to $185.24. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

**Signature:** /s/  Patrick W. Smith, by Isaiah Fields, Attorney-in-Fact  
**Date:** 2023-01-19

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**